Celocentesis: Current Evidence and Future Directions
Journal of Clinical Medicine · 13.03.2026 · 15 (6) · 2196
DOI: 10.3390/jcm15062196 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.03.2026. Verfasst von Fabiana Cecchini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Maternal Fetal Medicine Unit, Department of Women's and Children's, School of Medicine, University of Padova, 35131 Padova, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: This study aimed to review current evidence on celocentesis as an early invasive prenatal diagnostic technique, focusing on its clinical applications, diagnostic accuracy, safety profile, and future perspectives in modern fetal medicine.
Methods
A narrative review of the literature was conducted through PubMed and Scopus databases up to October 2025. Studies reporting original data on celocentesis—including prospective studies, case reports, and case series—were included. Relevant outcomes were feasibility, safety, and diagnostic accuracy.
Results
Since its first description in 1993, celocentesis has been successfully performed between 6 and 9 weeks’ gestation in several small case series. Improvements in ultrasound resolution and molecular analysis techniques have significantly enhanced its reliability. In specialized centers using dedicated fetal cell selection and contamination-control workflows, analytical diagnostic success for selected monogenic conditions exceeds 99%. Reported miscarriage rates are comparable to what is expected at a very early gestational age (10% of all clinically recognized pregnancies). The procedure remains mainly experimental, with no standardized protocols or large multicentric validation.
Conclusions
Celocentesis is the earliest available technique for prenatal genetic diagnosis. While promising, its clinical implementation requires further standardization, comprehensive operator training, and robust evidence from prospective studies regarding its safety and diagnostic reliability.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Maternal Fetal Medicine Unit, Department of Women's and Children's, School of Medicine, University of Padova, 35131 Padova, Italy.
- UOSD Diagnostica Molecolare Malattie Rare Ematologiche, AOOR Villa Sofia Cervello, 90100 Palermo, Italy.
- Unit of Fetal Medicine and Prenatal Diagnosis, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, 90146 Palermo, Italy.
- Department of Women's and Children's Health, University of Padova, 35128 Padova, Italy.
- Clinical Genetics Unit, Department of Women's and Children's Health, University of Padova, 35131 Padova, Italy.
- Obstetrics and Gynecology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
ORCID-Profile: Fabiana Cecchini, Silvia Visentin, Antonino Giambona, Alessandra Andrisani, Matteo Cassina, Ambrogio Pietro Londero
Zitieren
APA
Cecchini, F., Visentin, S., Giambona, A., Vinciguerra, M., Picciotto, F., Andrisani, A., Cassina, M., Londero, A. P., Nicolaides, K., & Cosmi, E. (2026). Celocentesis: Current Evidence and Future Directions. Journal of Clinical Medicine, 15(6), 2196. https://doi.org/10.3390/jcm15062196
Vancouver
Cecchini F, Visentin S, Giambona A, Vinciguerra M, Picciotto F, Andrisani A, et al. Celocentesis: Current Evidence and Future Directions. Journal of Clinical Medicine. 2026;15(6):2196. doi:10.3390/jcm15062196
BibTeX
@article{Cecchini2026,
author = {Cecchini, Fabiana and Visentin, Silvia and Giambona, Antonino and Vinciguerra, Margherita and Picciotto, Francesco and Andrisani, Alessandra and Cassina, Matteo and Londero, Ambrogio Pietro and Nicolaides, Kypros and Cosmi, Erich},
title = {Celocentesis: Current Evidence and Future Directions},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {6},
pages = {2196},
doi = {10.3390/jcm15062196}
}
EUVIMED